The March 2026 PBAC agenda includes a diverse set of therapies, spanning oncology, immunology, neurology, rare diseases, respiratory medicine and vaccines. …
March PBAC agenda confirms a diverse range of therapies up for consideration
November 19, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - -
Island secures USAMRIID partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech -
Cartherics secures Japanese patent to bolster cell therapy push
June 10, 2026 - - Australian Biotech -
GSK to buy Nuvalent in a major move to acquire rights to late stage lung cancer candidates
June 10, 2026 - - Latest News -
Australian company secures US fast track for CAR-T in blood cancers
June 10, 2026 - - Latest News -
Industry campaign highlights MFN risk to US jobs and the broader economy
June 10, 2026 - - Latest News -
New report highlights the potential health-system benefits of pharmacist prescribing
June 9, 2026 - - Latest News